Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claudia Gaspar is active.

Publication


Featured researches published by Claudia Gaspar.


Molecular Psychiatry | 2011

Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.

Amélie Piton; Julie Gauthier; Fadi F. Hamdan; Ronald G. Lafrenière; Yan Yang; Edouard Henrion; Sandra Laurent; Anne Noreau; Pascale Thibodeau; Karemera L; Dan Spiegelman; Kuku F; Duguay J; Destroismaisons L; Jolivet P; Mélanie Côté; Lachapelle K; Ousmane Diallo; Raymond A; Claude Marineau; Nathalie Champagne; Lan Xiong; Claudia Gaspar; Jean-Baptiste Rivière; Julien Tarabeux; Patrick Cossette; Marie-Odile Krebs; Judith L. Rapoport; Anjene Addington; Lynn E. DeLisi

Autism spectrum disorder (ASD) and schizophrenia (SCZ) are two common neurodevelopmental syndromes that result from the combined effects of environmental and genetic factors. We set out to test the hypothesis that rare variants in many different genes, including de novo variants, could predispose to these conditions in a fraction of cases. In addition, for both disorders, males are either more significantly or more severely affected than females, which may be explained in part by X-linked genetic factors. Therefore, we directly sequenced 111 X-linked synaptic genes in individuals with ASD (n=142; 122 males and 20 females) or SCZ (n=143; 95 males and 48 females). We identified >200 non-synonymous variants, with an excess of rare damaging variants, which suggest the presence of disease-causing mutations. Truncating mutations in genes encoding the calcium-related protein IL1RAPL1 (already described in Piton et al. Hum Mol Genet 2008) and the monoamine degradation enzyme monoamine oxidase B were found in ASD and SCZ, respectively. Moreover, several promising non-synonymous rare variants were identified in genes encoding proteins involved in regulation of neurite outgrowth and other various synaptic functions (MECP2, TM4SF2/TSPAN7, PPP1R3F, PSMD10, MCF2, SLITRK2, GPRASP2, and OPHN1).


Neurology | 1996

Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients

Isabel Silveira; I. Lopes-Cendes; Stephen J. Kish; P. Maciel; Claudia Gaspar; Paula Coutinho; M. I. Botez; H. Teive; W. Arruda; C. E. Steiner; W. Pinto-Junior; J. A. Maciel; S. Jain; G. Sack; Eva Andermann; Lewis Sudarsky; Roger N. Rosenberg; Patrick MacLeod; David Chitayat; Riyana Babul; Jorge Sequeiros; Guy A. Rouleau

Article abstract-The spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative disorders varying in both clinical manifestations and mode of inheritance. Six different genes causing autosomal dominant SCA are mapped: SCA1, SCA2, Machado-Joseph disease (MJD)/SCA3, SCA4, SCA5, and dentatorubropallidoluysian atrophy (DRPLA). Expansions of an unstable trinucleotide CAG repeat cause three of these disorders: SCA type 1 (SCA1), MJD, and DRPLA. We determined the frequency of the SCA1, DRPLA, and MJD mutations in a large group of unrelated SCA patients with various patterns of inheritance and different ethnic backgrounds. We studied 92 unrelated SCA patients. The frequency of the SCA1 mutation was 3% in the overall patient group and 10% in the non-Portuguese dominantly inherited SCA subgroup. We found the DRPLA mutation in only one Japanese patient, who was previously diagnosed with this disease. We identified the MJD mutation in 41% of the overall patient group, which included 38 autosomal dominant kindreds of Portuguese origin; the frequency of the MJD mutation among the non-Portuguese dominantly inherited cases was 17%. These results suggest that SCA may be occasionally caused by the SCA1 mutation and rarely caused by the DRPLA mutation and that, to date, the MJD mutation seems to be the most common cause of dominantly inherited SCA. Finally, our results suggest that recessively inherited cases of SCA are not caused by the known trinucleotide repeat expansions. NEUROLOGY 1996;46: 214-218


Human Molecular Genetics | 2009

MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels

Lan Xiong; Hélène Catoire; Patrick A. Dion; Claudia Gaspar; Ronald G. Lafrenière; Simon Girard; Anastasia Levchenko; Jean Baptiste Rivière; Laura M. Fiori; Judith St-Onge; Isabelle Bachand; Pascale Thibodeau; Richard Allen; Christopher J. Earley; Gustavo Turecki; Jacques Montplaisir; Guy A. Rouleau

Restless legs syndrome (RLS) is a common neurological disorder characterized by an irresistible urge to move the legs at night, which is often accompanied by unpleasant sensations. A recent genomewide association study identified an association between RLS and intronic markers from the MEIS1 gene. Comparative genomic analysis indicates that MEIS1 is the only gene encompassed in this evolutionarily conserved chromosomal segment, i.e. a conservation synteny block, from mammals to fish. We carried out a series of experiments to delineate the role of MEIS1 in RLS pathogenesis and the underlying genetic mechanism. We sequenced all 13 MEIS1 exons and their splice junctions in 285 RLS probands with confirmed clinical diagnosis and did not identify any causative coding or exon-intron junction mutations. We found no evidence of structural variation or disease-associated haplotype differential splicing. However, sequencing of conserved regions of MEIS1 introns 8 and 9 identified a novel single nucleotide polymorphism (C13B_2) significantly associated with RLS (allelic association, P = 1.81E-07). We detected a significant decrease in MEIS1 mRNA expression by quantitative real-time polymerase chain reaction in lymphoblastoid cell lines (LCLs) and brain tissues from RLS patients homozygous for the intronic RLS risk haplotype, compared with those homozygous for the non-risk haplotype. Finally, we found significantly decreased MEIS1 protein levels in the same batch of LCLs and brain tissues from the homozygous carriers of the risk haplotype, compared with the homozygous non-carriers. Therefore, these data suggest that reduced expression of the MEIS1 gene, possibly through intronic cis-regulatory element(s), predisposes to RLS.


American Journal of Medical Genetics | 1998

Analysis of SCA1, DRPLA, MJD, SCA2, and SCA6 CAG repeats in 48 portuguese ataxia families

Isabel Silveira; Paula Coutinho; P. Maciel; Claudia Gaspar; Hayes S; Dias A; João Guimarães; Leal Loureiro; Jorge Sequeiros; Guy A. Rouleau

The spinocerebellar ataxias (SCAs) are clinically and genetically a heterogeneous group of neurodegenerative disorders. To date, eight different loci causing SCA have been identified: SCA1, SCA2, Machado-Joseph disease (MJD)/SCA3, SCA4, SCA5, SCA6, SCA7, and dentatorubropallidoluysian atrophy (DRPLA). Expansion of a CAG repeat in the disease genes has been found in five of these disorders. To estimate the relative frequencies of the SCA1, DRPLA, MJD, SCA2, and SCA6 mutations among Portuguese ataxia patients, we collected DNA samples from 48 ataxia families and performed polymerase chain reaction (PCR) amplification of the CAG repeat mutations on chromosomes 6p, 12p, 14q, 12q, and 19p, respectively. Fifty-five individuals belonging to 34 dominant families (74%) had an expanded CAG repeat at the MJD gene. In five individuals from two kindreds with a dominant pattern of inheritance (4%), an expanded CAG repeat at the SCA2 gene was found. In MJD patients, the normal allele size ranged from 13 to 41, whereas the mutant alleles contained 65 to 80 repeats. For the SCA2 patients, normal alleles had 22 or 23, while expanded alleles had between 36 and 47 CAG units. We did not find the SCA1, DRPLA, or SCA6 mutations in our group of families. The MJD mutation remains the most common cause of SCA in Portugal, while a small number of cases are caused by mutations at the SCA2 gene, and 22% are due to still unidentified genes.


Annals of Neurology | 2011

Restless legs syndrome‐associated MEIS1 risk variant influences iron homeostasis

Hélène Catoire; Patrick A. Dion; Lan Xiong; Mourabit Amari; Rébecca Gaudet; Simon Girard; Anne Noreau; Claudia Gaspar; Gustavo Turecki; Jacques Montplaisir; J. Alex Parker; Guy A. Rouleau

Restless legs syndrome (RLS) is a frequent sleep disorder that is linked to disturbed iron homeostasis. Genetic studies identified MEIS1 as an RLS‐predisposing gene, where the RLS risk haplotype is associated with decreased MEIS1 mRNA and protein expression. We show here that RNA interference treatment of the MEIS1 worm orthologue increases ferritin expression in Caenorhabditis elegans and that the RLS‐associated haplotype leads to increased expression of ferritin and DMT1 in RLS brain tissues. Additionally, human cells cultured under iron‐deficient conditions show reduced MEIS1 expression. Our data establish a link between the RLS MEIS1 gene and iron metabolism. Ann Neurol 2011;


Neurology | 2007

CANADIAN RESTLESS LEGS SYNDROME TWIN STUDY

Lan Xiong; K. Jang; J. Montplaisir; Anastasia Levchenko; Pascale Thibodeau; Claudia Gaspar; Gustavo Turecki; Guy A. Rouleau

Restless legs syndrome (RLS) is a common sensorimotor disorder1 where familial aggregation strongly suggests an important genetic component. However, the underlying genetic structure remains largely unknown. Due to its recent acceptance as a clinical entity and the development of standard diagnostic criteria and reliable assessment instruments,1 few and incomplete RLS twin studies have been published.2,3 ### Methods. A validated 36-item RLS questionnaire, used for our family studies of RLS4 and reformatted to be self-administered, and a standard zygosity questionnaire were individually mailed to 600 adult co-twins (age 18 years and older) from the University of British Columbia (UBC) twin registry across Canada.5 An additional 86 co-twins were identified through our family studies in Quebec (Universite de Montreal [UdeM]) and were telephone interviewed by a trained research associate using the same questionnaires. The pairs with mean zygosity scores of ≥4 were classified as monozygotic (MZ) and all others as dizygotic (DZ).6 Only individuals fulfilling all four diagnostic criteria1 were classified as definite RLS; individuals missing one essential diagnostic criterion but having one or more supporting …


Neurobiology of Disease | 2005

Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice.

Patrick A. Dion; Vijayalakshmi Shanmugam; Claudia Gaspar; Christiane Messaed; Inge Meijer; André Toulouse; Janet Laganière; Julie Roussel; Daniel Rochefort; Simon Laganiere; Carol Allen; George Karpati; Jean-Pierre Bouchard; Bernard Brais; Guy A. Rouleau

Oculopharyngeal muscular dystrophy (OPMD) is a late-onset disorder caused by a (GCG)n trinucleotide repeat expansion in the poly(A) binding protein nuclear-1 (PABPN1) gene, which in turn leads to an expanded polyalanine tract in the protein. We generated transgenic mice expressing either the wild type or the expanded form of human PABPN1, and transgenic animals with the expanded form showed clear signs of abnormal limb clasping, muscle weakness, coordination deficits, and peripheral nerves alterations. Analysis of mitotic and postmitotic tissues in those transgenic animals revealed ubiquitinated PABPN1-positive intranuclear inclusions (INIs) in neuronal cells. This latter observation led us to test and confirm the presence of similar INIs in postmortem brain sections from an OPMD patient. Our results indicate that expanded PABPN1, presumably via the toxic effects of its polyalanine tract, can lead to inclusion formation and neurodegeneration in both the mouse and the human.


JAMA Neurology | 2010

Family Study of Restless Legs Syndrome in Quebec, Canada: Clinical Characterization of 671 Familial Cases

Lan Xiong; Jacques Montplaisir; Alex Desautels; Amina Barhdadi; Gustavo Turecki; Anastasia Levchenko; Pascale Thibodeau; Marie-Pierre Dubé; Claudia Gaspar; Guy A. Rouleau

OBJECTIVES To fully ascertain the familial aggregation of restless legs syndrome (RLS) and to characterize the clinical features of familial RLS (fRLS) cases. DESIGN A case series survey with a high response rate. SETTING Academic research center. PARTICIPANTS Consecutive RLS probands (n = 249) were followed up in a specialized sleep center for 15 years. A total of 671 cases of fRLS met the current standard diagnostic criteria, including 192 probands characterized using multidimensional clinical assessments and 479 affected family members assessed by their responses to a structured questionnaire telephone diagnostic interview. MAIN OUTCOME MEASURES Sibling and offspring relative risk ratio and clinical and genetic features of patients with fRLS and families. RESULTS Our data showed that RLS aggregates in families with a familial rate of 77%, a sibling relative risk of 3.6 (95% confidence interval, 2.8-4.4), and an offspring relative risk of 1.8 (1.0-2.7). Familial RLS is a chronic disorder with a mean (SD) disease duration of 24 (16) years and a wide range of age of onset (mean [SD], 28 [15] years), with most family members having early-onset disease but mild to moderate RLS symptoms. Our clinical data also indicated that fRLS is more prominent among women who also had increased incidence of anemia/iron deficiency, arthritis, and number of pregnancies. Pregnancy-related RLS seems to be a characteristic feature of fRLS, and afflicted women tend to have a much younger age of onset. CONCLUSIONS Restless legs syndrome significantly aggregated in families with variable phenotypic expressivity, and the siblings of severely affected individuals have an increased risk of developing the disease.


Movement Disorders | 2009

Autosomal-dominant locus for restless legs syndrome in French-Canadians on chromosome 16p12.1†

Anastasia Levchenko; J. Montplaisir; Géraldine Asselin; Sylvie Provost; Simon Girard; Lan Xiong; Emmanuelle Lemyre; Judith St-Onge; Pascale Thibodeau; Alex Desautels; Gustavo Turecki; Claudia Gaspar; Marie-Pierre Dubé; Guy A. Rouleau

We describe an autosomal‐dominant locus for Restless Legs Syndrome (RLS) in a French‐Canadian (FC) pedigree. Genome‐wide microsatellite scan and linkage analysis were used in this study. The locus maps to chromosome 16p12.1 and spans 1.18 Mega bases. The maximum multipoint LOD scores are of 3.5 over the total of 10 markers. Evidence for the same locus was also found in a smaller FC pedigree sime095. The analysis of the sequence of 8 annotated genes within the region did not reveal any pathogenic mutations. Copy number variation and karyotype analyses did not reveal any chromosomal abnormality in the region. Further analyses of the region are necessary to find the genetic cause of RLS in this family.


JAMA Neurology | 2009

Association of Intronic Variants of the BTBD9 Gene With Tourette Syndrome

Jean-Baptiste Rivière; Lan Xiong; Anastasia Levchenko; Judith St-Onge; Claudia Gaspar; Yves Dion; Paul Lespérance; Geneviève Tellier; Francois Richer; Sylvain Chouinard; Guy A. Rouleau

OBJECTIVE To test the association between Tourette syndrome (TS) and genetic variants in genomic loci MEIS1, MAP2K5/LBXCOR1, and BTBD9, for which genome-wide association studies in restless legs syndrome and periodic limb movements during sleep revealed common risk variants. DESIGN Case-control association study. SETTING Movement disorder clinic in Montreal. Subjects We typed 14 single-nucleotide polymorphisms spanning the 3 genomic loci in 298 TS trios, 322 TS cases (including 298 probands from the cohort of TS trios), and 290 control subjects. MAIN OUTCOME MEASURES Clinical diagnosis of TS, obsessive-compulsive disorder, and attention-deficit disorder. RESULTS The study provided 3 single-nucleotide polymorphisms within BTBD9 associated with TS (chi(2) = 8.02 [P = .005] for rs9357271), with the risk alleles for restless legs syndrome and periodic limb movements during sleep overrepresented in the TS cohort. We stratified our group of patients with TS according to presence or absence of obsessive-compulsive disorder and/or attention-deficit disorder and found that variants in BTBD9 were strongly associated with TS without obsessive-compulsive disorder (chi(2) = 12.95 [P < .001] for rs9357271). Furthermore, allele frequency of rs9357271 inversely correlated with severity of obsessive-compulsive disorder as measured by the Yale-Brown Obsessive Compulsive Scale score. CONCLUSION Variants in BTBD9 that predispose to restless legs syndrome and periodic limb movements during sleep are also associated with TS, particularly TS without obsessive-compulsive disorder.

Collaboration


Dive into the Claudia Gaspar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Patrick A. Dion

Montreal Neurological Institute and Hospital

View shared research outputs
Top Co-Authors

Avatar

Lan Xiong

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gustavo Turecki

Douglas Mental Health University Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge